DocGo vs Omada Health
DCGO and OMDA side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DCGO and OMDA compare
Omada Health is the larger company, worth 43 times as much as DocGo ($877M against $20.5M).
Omada Health grew revenue faster over the last twelve months (43.3% versus −19.2% for DocGo).
Omada Health keeps more of each dollar of sales as profit, with a net margin of 4.2% compared with −61.0% at DocGo.
Omada Health scores higher on the StockData Score (13 against 6 for DocGo), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DCGO | OMDA |
|---|---|---|
| Size and price | ||
| Market cap | $20.5M | $877M |
| Share price | $0.208 | $14.33 |
| Change, 1 year | −80.9% | −33.2% |
| Change, 5 years | −97.8% | – |
| Beta (5Y) | 1.24 | 2.29 |
| Employees | 3,600 | 916 |
| StockData Score | ||
| Total score | 6 | 13 (better) |
| Valuation score | 3 (better) | 1 |
| Growth score | 0 | 3 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 3 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.1× (better) | 2.6× |
| P/B | 0.2× (better) | 3.2× |
| EV/EBITDA | – | 48.5× |
| P/FCF | – | 31.2× |
| FCF yield | −148% | 3.2% (better) |
| Fair value | $2.15 | $9.16 |
| Margin of safety | 90.3% (better) | −56.4% |
| Growth | ||
| Revenue growth (TTM) | −19.2% | 43.3% (better) |
| Revenue growth, 5Y average | 27.9% | – |
| Profitability | ||
| Gross margin | – | 70.7% |
| Operating margin | −53.3% | 2.1% (better) |
| Net margin | −61.0% | 4.2% (better) |
| FCF margin | −10.2% | 8.5% (better) |
| Return on equity | −96.5% | 5.7% (better) |
| Return on invested capital | −88.3% | 28.2% (better) |
| Financial health | ||
| Debt / equity | 0.00 (better) | 0.00 |
| Interest coverage | – | 22.4× |
| Current ratio | 1.38 | 4.18 (better) |
| Altman Z-score | −2.82 | 7.03 (better) |
| Piotroski F-score | 3 | 7 (better) |
| Dividends and buybacks | ||
| Buyback yield | 0.00% | – |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 38.5% | 85.9% |
| Held by insiders | 9.8% | 5.4% |
| Insider net buying, 12 months | −$15.3K (better) | −$14.6M |
| Short interest, % of float | 2.4% | 15.8% |
Go deeper
- DCGO stock overview
- DCGO income statement
- DCGO valuation and score
- OMDA stock overview
- OMDA income statement
- OMDA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.